Answer
The safety and efficacy of carfilzomib (Kyprolis) in children have not been established, and no data are available.
Sources for this answer
- KyprolisAmgen Ltd · emc · SmPC §4.2 Posology and method of administration · Version 21Document updated
Sources checked